Growth of molecular imaging industry expected to continue

05/30/2013 | MolecularImaging.net

The molecular imaging industry is poised to continue growing, driven by emerging markets and growth of hybrid modalities such as PET/CT, according to a report from Espicom Business Intelligence. The report also noted a trend toward increased use of PET as an alternative to SPECT and the emergence of scalable and cost-effective cyclotrons. Cardiology, oncology and neurology -- dementia in particular -- are all robust growth areas.

View Full Article in:

MolecularImaging.net

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX